AOCOPM 2024 Midyear Educational Conference-R - Pearls in Clinical Preventive Medicine: Current USPSTF and Healthy People 2030 Guidelines

R - Pearls in Clinical Preventive Medicine: Current USPSTF and Healthy People 2030 Guidelines - Lisa Klatka, DO, MS, FAOCOPM

Back to course

Video Transcription

Video Summary

Dr. Lisa Clacka, a past president and fellow of the college, presents a lecture on "pearls in clinical preventive medicine," focusing on the U.S. Preventive Services Task Force and Healthy People 2030. She highlights their role in making evidence-based recommendations for preventive services, such as screening and vaccinations. The task force, consisting of 16 volunteers from primary and public health sectors, assigns letter grades to recommendations, where A and B are advised for significant to moderate benefits, respectively. Clacka explores cervical cancer within a case study, discussing its decreased incidence due to improved screening. She explains screening guidelines shift from annual Paps and emphasizes HPV’s role in cervical cancer. The presentation transitions to discussing breast cancer screening, recently adjusted to commence at age 40, focusing on disparities among demographics. Clacka provides a brief on male health, covering colorectal and prostate cancers, emphasizing evidence-based screenings. She touches on colorectal cancer screenings starting at age 45 and prostate cancer’s debated screening effectiveness due to treatment side effects versus cancer lethality. Lastly, she alludes to lung cancer screenings for smokers, highlighting low compliance rates. This comprehensive overview encourages adherence to updated preventive health guidelines.

Keywords

preventive medicine

U.S. Preventive Services Task Force

Healthy People 2030

screening recommendations

cervical cancer

breast cancer

colorectal cancer

prostate cancer

lung cancer